Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Meggy P.M. Ottenheijm"'
Autor:
Yvonne Wesseling-Rozendaal, Marjolein H.F.M. Lentjes-Beer, Jurgen M.J. Piek, Joanne A. de Hullu, Ruud L.M. Bekkers, Caroline Vos, Anja van de Stolpe, Steven L. Bosch, Laura A.M. van Lieshout, Meggy P.M. Ottenheijm, Leon F.A.G. Massuger, Phyllis van der Ploeg, Annelen Meriaan
Publikováno v:
Cancers
Volume 13
Issue 20
Cancers, 13(20):5101. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 5101, p 5101 (2021)
Cancers, 13
Cancers, 13, 20
Volume 13
Issue 20
Cancers, 13(20):5101. Multidisciplinary Digital Publishing Institute (MDPI)
Cancers, Vol 13, Iss 5101, p 5101 (2021)
Cancers, 13
Cancers, 13, 20
High-grade serous ovarian carcinoma (HGSC), the most common subtype of ovarian cancer, has a high mortality rate. Although there are some factors associated with survival, such as stage of disease, there are remarkable differences in survival among w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36624e788cfa97a02203274693515ee3
Autor:
Phyllis van der Ploeg, Anna M.J. Thijs, Jurgen M. J. Piek, Laura A.M. van Lieshout, Anja van de Stolpe, Steven L. Bosch, Ruud L.M. Bekkers, Meggy P.M. Ottenheijm
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Therapy targeting the estrogen receptor (ER) pathway is being explored as a treatment option in ovarian carcinoma. However, studies on the efficacy of anti-estrogen therapy include a broad range of histological subtypes and/or do not select patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab1d98727d66dcd84ece472a0cf92e31
https://doi.org/10.26502/jcsct.5079072
https://doi.org/10.26502/jcsct.5079072